MX358576B - Aglomeracion de nanoparticulas recubiertas con alcoxisilano magnetico. - Google Patents
Aglomeracion de nanoparticulas recubiertas con alcoxisilano magnetico.Info
- Publication number
- MX358576B MX358576B MX2014001186A MX2014001186A MX358576B MX 358576 B MX358576 B MX 358576B MX 2014001186 A MX2014001186 A MX 2014001186A MX 2014001186 A MX2014001186 A MX 2014001186A MX 358576 B MX358576 B MX 358576B
- Authority
- MX
- Mexico
- Prior art keywords
- alkoxysilane
- agglomerates
- magnetic
- present
- coated metal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/695—Silicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5192—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01F—MAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES
- H01F1/00—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01F—MAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES
- H01F1/00—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties
- H01F1/0036—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties showing low dimensional magnetism, i.e. spin rearrangements due to a restriction of dimensions, e.g. showing giant magnetoresistivity
- H01F1/0045—Zero dimensional, e.g. nanoparticles, soft nanoparticles for medical/biological use
- H01F1/0054—Coated nanoparticles, e.g. nanoparticles coated with organic surfactant
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01F—MAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES
- H01F41/00—Apparatus or processes specially adapted for manufacturing or assembling magnets, inductances or transformers; Apparatus or processes specially adapted for manufacturing materials characterised by their magnetic properties
- H01F41/14—Apparatus or processes specially adapted for manufacturing or assembling magnets, inductances or transformers; Apparatus or processes specially adapted for manufacturing materials characterised by their magnetic properties for applying magnetic films to substrates
- H01F41/16—Apparatus or processes specially adapted for manufacturing or assembling magnets, inductances or transformers; Apparatus or processes specially adapted for manufacturing materials characterised by their magnetic properties for applying magnetic films to substrates the magnetic material being applied in the form of particles, e.g. by serigraphy, to form thick magnetic films or precursors therefor
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nanotechnology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Power Engineering (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Manufacturing & Machinery (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Compounds Of Iron (AREA)
- Soft Magnetic Materials (AREA)
- Hard Magnetic Materials (AREA)
- Electrotherapy Devices (AREA)
- Manufacture Of Metal Powder And Suspensions Thereof (AREA)
- Powder Metallurgy (AREA)
Abstract
La presente invención se refiere a un método para producir una suspensión de aglomerados de nanopartículas de metal recubiertas con alcoxisilano magnético, en donde una suspensión acuosa de nanopartículas de metal magnético se incuba con alcoxisilano, en donde la incubación se lleva a cabo esencialmente en ausencia de un solvente orgánico. La presente invención se refiere además a la suspensión de aglomerados de nanopartículas que contienen metal recubiertas con alcoxisilano magnético que se pueden obtener por el método de la presente invención y a una composición que comprende aglomerados de nanopartículas de metal recubiertas con alcoxisilano magnético, en donde los aglomerados tienen un tamaño promedio de 30-450 nm, preferiblemente de 50 a 350 nm y especialmente de 70 a 300 nm como es determinado por dispersión de luz.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161522217P | 2011-08-10 | 2011-08-10 | |
| PCT/EP2012/003381 WO2013020701A2 (en) | 2011-08-10 | 2012-08-07 | Agglomerating magnetic alkoxysilane-coated nanoparticles |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2014001186A MX2014001186A (es) | 2014-05-13 |
| MX358576B true MX358576B (es) | 2018-08-27 |
Family
ID=46690467
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2014001186A MX358576B (es) | 2011-08-10 | 2012-08-07 | Aglomeracion de nanoparticulas recubiertas con alcoxisilano magnetico. |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US9408912B2 (es) |
| EP (2) | EP3038115B1 (es) |
| JP (1) | JP5844902B2 (es) |
| KR (1) | KR101513841B1 (es) |
| CN (1) | CN104620334B (es) |
| AU (1) | AU2012292554B2 (es) |
| BR (1) | BR112014002726A8 (es) |
| CA (1) | CA2844774C (es) |
| CL (1) | CL2014000298A1 (es) |
| CO (1) | CO6940414A2 (es) |
| DE (1) | DE202012012795U1 (es) |
| DK (1) | DK2742515T3 (es) |
| ES (2) | ES2807209T3 (es) |
| HK (1) | HK1210317A1 (es) |
| IL (1) | IL230799A (es) |
| MX (1) | MX358576B (es) |
| PL (2) | PL3038115T3 (es) |
| PT (1) | PT2742515T (es) |
| RU (1) | RU2622025C2 (es) |
| WO (1) | WO2013020701A2 (es) |
| ZA (1) | ZA201400564B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10513616B2 (en) | 2014-06-06 | 2019-12-24 | The Regents Of The University Of California | Sunlight reflecting materials and methods of fabrication |
| WO2021152136A1 (en) | 2020-01-31 | 2021-08-05 | Magforce Ag | Paste comprising magnetic alkoxysilane-coated metal containing nanoparticles |
| DE102020116859A1 (de) | 2020-06-26 | 2021-12-30 | Pharma Development Holding Gmbh | Liposomen |
| KR102503870B1 (ko) * | 2021-01-08 | 2023-02-24 | 한밭대학교 산학협력단 | 온열치료용 산화철 나노 클러스터 및 이의 제조 방법 |
Family Cites Families (85)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3945945A (en) | 1971-05-10 | 1976-03-23 | Norton Company | High surface area alumina bodies |
| US4169912A (en) | 1975-10-02 | 1979-10-02 | Dynamit Nobel Aktiengesellschaft | Iron oxide magnetic pigments for the production of magnetic coatings |
| DE2543962A1 (de) | 1975-10-02 | 1977-04-14 | Dynamit Nobel Ag | Verbesserte eisenoxid-magnetpigmente fuer die herstellung von magnetschichten |
| CA1254238A (en) | 1985-04-30 | 1989-05-16 | Alvin P. Gerk | Process for durable sol-gel produced alumina-based ceramics, abrasive grain and abrasive products |
| US5597531A (en) * | 1985-10-04 | 1997-01-28 | Immunivest Corporation | Resuspendable coated magnetic particles and stable magnetic particle suspensions |
| US4827945A (en) | 1986-07-03 | 1989-05-09 | Advanced Magnetics, Incorporated | Biologically degradable superparamagnetic materials for use in clinical applications |
| FR2618084B1 (fr) | 1987-07-15 | 1989-11-10 | Rhone Poulenc Chimie | Microspheres magnetisables a base de polysiloxane, leur procede de preparation et leur application en biologie |
| EP0670167A1 (en) | 1988-08-04 | 1995-09-06 | Advanced Magnetics Incorporated | Receptor mediated endocytosis type diagnostic agents |
| EP0451152B1 (en) | 1988-10-13 | 1993-08-25 | Tioxide Specialties Limited | Ceramic powders |
| US5460831A (en) | 1990-06-22 | 1995-10-24 | The Regents Of The University Of California | Targeted transfection nanoparticles |
| US5462751A (en) | 1990-06-22 | 1995-10-31 | The Regeants Of The University Of California | Biological and pharmaceutical agents having a nanomeric biodegradable core |
| DE4026978A1 (de) | 1990-08-25 | 1992-02-27 | Bayer Ag | Auf traegern angebrachte ein- oder mehrlagige schichtelemente und ihre herstellung |
| US5616311A (en) | 1991-01-15 | 1997-04-01 | Hemosphere, Inc. | Non-crosslinked protein particles for therapeutic and diagnostic use |
| JP3389611B2 (ja) | 1992-02-28 | 2003-03-24 | 戸田工業株式会社 | 無機物粒子含有樹脂複合球状物粉体 |
| DE4212633A1 (de) | 1992-04-15 | 1993-10-21 | Inst Neue Mat Gemein Gmbh | Verfahren zur Herstellung oberflächenmodifizierter nanoskaliger keramischer Pulver |
| ATE207727T1 (de) | 1992-05-29 | 2001-11-15 | Univ California | Beschichtetes transplantat sowie herstellungsverfahren dafür |
| DE69332082T2 (de) | 1992-11-06 | 2003-02-06 | Hisamitsu Pharmaceutical Co., Inc. | Perorale pharmazeutische zubereitung mit freisetzung im unteren verfdauungstrakt |
| US5401313A (en) | 1993-02-10 | 1995-03-28 | Harcros Pigments, Inc. | Surface modified particles and method of making the same |
| EP0689430B1 (de) | 1993-03-17 | 1997-08-13 | Silica Gel Ges.M.B.H | Superparamagnetische teilchen, verfahren zu ihrer herstellung und verwendung derselben |
| JPH06270155A (ja) | 1993-03-23 | 1994-09-27 | Sekisui Chem Co Ltd | 型内被覆用樹脂組成物 |
| US5547748A (en) | 1994-01-14 | 1996-08-20 | Sri International | Carbon nanoencapsulates |
| FR2721615A1 (fr) | 1994-06-24 | 1995-12-29 | Rhone Poulenc Chimie | Procédé de préparation de particules d'oxyde métallique organophiles. |
| KR970705154A (ko) | 1994-07-07 | 1997-09-06 | 아서 에스. 모겐스턴 | 고 분산성 자기 금속 산화 입자 및 이의 제조방법(highly disperse magnetic metal oxide particles, processes for their preparation and their use) |
| JP3436760B2 (ja) | 1994-07-27 | 2003-08-18 | ハーバート ピルグリム | 超常磁性粒子 |
| US6103379A (en) | 1994-10-06 | 2000-08-15 | Bar-Ilan University | Process for the preparation of microspheres and microspheres made thereby |
| GB9420390D0 (en) | 1994-10-10 | 1994-11-23 | Nycomed Salutar Inc | Liposomal agents |
| US5540959A (en) | 1995-02-21 | 1996-07-30 | Howard J. Greenwald | Process for preparing a coated substrate |
| DE19515820A1 (de) | 1995-04-29 | 1996-10-31 | Inst Neue Mat Gemein Gmbh | Verfahren zur Herstellung schwach agglomerierter nanoskaliger Teilchen |
| JPH09646A (ja) | 1995-06-16 | 1997-01-07 | Toshiba Corp | 治療用誘導加熱装置 |
| US6022500A (en) | 1995-09-27 | 2000-02-08 | The United States Of America As Represented By The Secretary Of The Army | Polymer encapsulation and polymer microsphere composites |
| US5695900A (en) * | 1995-12-21 | 1997-12-09 | Colorado School Of Mines | Surface treatment of magnetic particles for use in reprographic processes |
| US5922403A (en) | 1996-03-12 | 1999-07-13 | Tecle; Berhan | Method for isolating ultrafine and fine particles |
| DE19612001A1 (de) | 1996-03-18 | 1997-09-25 | Silica Gel Gmbh Adsorptions Te | Superparamagnetische Teilchen mit vergrößerter R¶1¶-Relaxivität, Verfahren zur Herstellung und deren Verwendung |
| DE19614136A1 (de) | 1996-04-10 | 1997-10-16 | Inst Neue Mat Gemein Gmbh | Verfahren zur Herstellung agglomeratfreier nanoskaliger Eisenoxidteilchen mit hydrolysebeständigem Überzug |
| US5922537A (en) | 1996-11-08 | 1999-07-13 | N.o slashed.AB Immunoassay, Inc. | Nanoparticles biosensor |
| WO1998040049A2 (de) | 1997-03-07 | 1998-09-17 | Max-Delbrück-Centrum für Molekulare Medizin | Spezifische magnetosomen, verfahren zu ihrer herstellung und ihre verwendung |
| DE19716732C2 (de) | 1997-03-07 | 1999-03-25 | Max Delbrueck Centrum | Spezifische Magnetosomen, Verfahren zu ihrer Herstellung und ihre Verwendung |
| ATE226226T1 (de) * | 1997-05-23 | 2002-11-15 | Bayer Ag | Organosilan-oligomere |
| DE19726282A1 (de) | 1997-06-20 | 1998-12-24 | Inst Neue Mat Gemein Gmbh | Nanoskalige Teilchen mit einem von mindestens zwei Schalen umgebenen eisenoxid-haltigen Kern |
| DE19912502A1 (de) | 1999-03-19 | 2000-09-21 | Inst Neue Mat Gemein Gmbh | Nanoskalige Teilchen, Komplexe mit Polynukleotiden und deren Verwendung |
| DE19921088C2 (de) | 1999-04-30 | 2003-08-07 | Magforce Applic Gmbh | Stent zur Offenhaltung gangartiger Strukturen |
| DE19940220B4 (de) | 1999-08-19 | 2007-05-03 | Magforce Nanotechnologies Ag | Medizinisches Präparat zur Behandlung von Arthrose, Arthritis und anderen rheumatischen Gelenkerkrankungen |
| US6548264B1 (en) | 2000-05-17 | 2003-04-15 | University Of Florida | Coated nanoparticles |
| US20030092029A1 (en) | 2001-06-06 | 2003-05-15 | Lee Josephson | Magneitc-nanoparticle conjugates and methods of use |
| US20040156852A1 (en) | 2003-02-06 | 2004-08-12 | Triton Biosystems, Inc. | Therapy via targeted delivery of nanoscale particles |
| US7731648B2 (en) | 2001-07-25 | 2010-06-08 | Aduro Biotech | Magnetic nanoscale particle compositions, and therapeutic methods related thereto |
| DE10153639A1 (de) * | 2001-10-31 | 2003-05-22 | Inst Neue Mat Gemein Gmbh | Superparamagnetisches Eisenoxid enthaltende Kompositpartikel |
| DE10261406A1 (de) | 2002-12-30 | 2004-07-15 | Sustech Gmbh & Co. Kg | Verfahren zur Herstellung oberflächenbeschichteter nanoskaliger Teilchen und von Suspensionen, die diese enthalten |
| US20040156846A1 (en) | 2003-02-06 | 2004-08-12 | Triton Biosystems, Inc. | Therapy via targeted delivery of nanoscale particles using L6 antibodies |
| DE10331439B3 (de) | 2003-07-10 | 2005-02-03 | Micromod Partikeltechnologie Gmbh | Magnetische Nanopartikel mit verbesserten Magneteigenschaften |
| US20050119725A1 (en) | 2003-04-08 | 2005-06-02 | Xingwu Wang | Energetically controlled delivery of biologically active material from an implanted medical device |
| FR2855315B1 (fr) | 2003-05-23 | 2005-08-19 | Centre Nat Rech Scient | Ferrofluides stables en milieu neutre et ferrofluides modifies obtenus par modification de la surface des particules de ces ferrofluides |
| US8651113B2 (en) | 2003-06-18 | 2014-02-18 | Swr&D Inc. | Magnetically responsive nanoparticle therapeutic constructs and methods of making and using |
| US7531149B2 (en) | 2003-10-14 | 2009-05-12 | The Board Of Trustees Of The University Of Arkansas | Synthetic control of metal oxide nanocrystal sizes and shapes |
| US20050090732A1 (en) | 2003-10-28 | 2005-04-28 | Triton Biosystems, Inc. | Therapy via targeted delivery of nanoscale particles |
| DE102004052533A1 (de) | 2004-10-15 | 2006-05-04 | Mykhaylyk, Olga, Dr. | Magnetische Partikel zur Verwendung in Therapie und Diagnostik |
| WO2006057467A1 (en) | 2004-11-26 | 2006-06-01 | Seoul National University Industry Foundation | Method for large-scale production of monodisperse nanoparticles |
| US7462446B2 (en) | 2005-03-18 | 2008-12-09 | University Of Washington | Magnetic nanoparticle compositions and methods |
| DE102005016873A1 (de) | 2005-04-12 | 2006-10-19 | Magforce Nanotechnologies Ag | Nanopartikel-Wirstoff-Konjugate |
| WO2006125452A1 (en) | 2005-05-23 | 2006-11-30 | Universite De Geneve | Injectable superparamagnetic nanoparticles for treatment by hyperthermia and use for forming an hyperthermic implant |
| GB0512374D0 (en) | 2005-06-17 | 2005-07-27 | Nanosphere Ltd | Coated microspheres |
| DE102005039579B4 (de) | 2005-08-19 | 2022-06-30 | Magforce Ag | Verfahren zur Einschleusung von therapeutischen Substanzen in Zellen |
| US20070269380A1 (en) | 2005-10-11 | 2007-11-22 | Washington, University Of | Methotrexate-modified nanoparticles and related methods |
| DE102005059751A1 (de) | 2005-12-09 | 2007-06-14 | Ferropharm Gmbh Forschungslabor | Wässrige Dispersion von superparamagnetischen Eindomänenteilchen, deren Herstellung und Verwendung zur Diagnose und Therapie |
| JP2008019202A (ja) * | 2006-07-12 | 2008-01-31 | Koichi Jinbo | メラノーマ標的温熱免疫療法治療剤 |
| CH697953B1 (fr) | 2006-07-31 | 2010-01-29 | Ecole Polytech | Nanoparticules à noyau métallique recouvert de silice. |
| TWI321133B (en) | 2006-08-01 | 2010-03-01 | Univ Kaohsiung Medical | Folate-receptor-targeting iron oxide nanoparticles coated with poly(ethylene glycol) |
| RU2373957C2 (ru) | 2006-10-13 | 2009-11-27 | Александр Метталинович Тишин | Носитель для лекарственных средств и биологически активных веществ для лечения и диагностики и применение его для создания лекарственных средств и способа регулируемой управляемой доставки лекарственного средства или биологически активного вещества с регулируемой десорбцией его |
| EP1935436A1 (en) | 2006-12-12 | 2008-06-25 | Dublin City University | Nanoparticle clusters and methods for forming same |
| JP5057208B2 (ja) * | 2006-12-20 | 2012-10-24 | 株式会社豊田中央研究所 | 磁性材料の製造方法 |
| US20110104073A1 (en) | 2007-01-18 | 2011-05-05 | Qi Zeng | Iron/Iron Oxide Nanoparticle and Use Thereof |
| EP1952919B1 (en) | 2007-02-02 | 2013-04-24 | FUJIFILM Corporation | Magnetic nanoparticles and aqueous colloid composition containing the same |
| JP2011512238A (ja) | 2008-01-04 | 2011-04-21 | スパルクシス・ビー．ブイ． | 金属酸化物のナノ粒子の表面修飾 |
| DE102008003615A1 (de) * | 2008-01-09 | 2009-07-16 | Magforce Nanotechnologies Ag | Magnetische Transducer |
| WO2009094568A1 (en) | 2008-01-23 | 2009-07-30 | The Regents Of The University Of California | Nano-devices having impellers for capture and release of molecules |
| DE102008008522A1 (de) | 2008-02-11 | 2009-08-13 | Magforce Nanotechnologies Ag | Implantierbare Nanopartikel-enthaltende Produkte |
| US20090226376A1 (en) | 2008-03-05 | 2009-09-10 | General Electric Company | Novel Mixed Ligand Core/Shell Iron Oxide Nanoparticles for Inflammation Imaging |
| WO2010062615A1 (en) | 2008-10-27 | 2010-06-03 | Board Of Trustees Of The University Of Arkansas | Metallic nanoparticles with coated shells and applications of same |
| GB2472446A (en) | 2009-08-07 | 2011-02-09 | Ct Fuer Angewandte Nanotechnologie | Metal oxide particles coated with polyethylene glycol and their synthesis |
| DE102009058769A1 (de) | 2009-12-16 | 2011-06-22 | MagForce Nanotechnologies AG, 10589 | Temperaturabhängige Aktivierung von katalytischen Nukleinsäuren zur kontrollierten Wirkstofffreisetzung |
| EP2383374A1 (en) | 2010-04-29 | 2011-11-02 | BASF Corporation | Nano-particles containing carbon and a ferromagnetic metal or alloy |
| WO2011150212A2 (en) | 2010-05-26 | 2011-12-01 | The General Hospital Corporation | Magnetic nanoparticles |
| JP2013529677A (ja) | 2010-06-29 | 2013-07-22 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | 磁気粒子イメージング（ｍｐｉ）のための高性能鉄酸化物粒子トレーサーの合成 |
| TW201247225A (en) | 2011-05-17 | 2012-12-01 | Univ Nat Chiao Tung | Drug carrier with thermal sensitivity, manufacturing method thereof, and use of the same as NMR contrast agent |
| US10220004B2 (en) | 2011-07-14 | 2019-03-05 | The Regents Of The University Of California | Method of controlled delivery using sub-micron-scale machines |
-
2012
- 2012-08-07 ES ES16000350T patent/ES2807209T3/es active Active
- 2012-08-07 PL PL16000350T patent/PL3038115T3/pl unknown
- 2012-08-07 ES ES12748166.1T patent/ES2582283T3/es active Active
- 2012-08-07 KR KR1020147005840A patent/KR101513841B1/ko active IP Right Grant
- 2012-08-07 PL PL12748166T patent/PL2742515T3/pl unknown
- 2012-08-07 MX MX2014001186A patent/MX358576B/es active IP Right Grant
- 2012-08-07 CA CA2844774A patent/CA2844774C/en active Active
- 2012-08-07 PT PT127481661T patent/PT2742515T/pt unknown
- 2012-08-07 WO PCT/EP2012/003381 patent/WO2013020701A2/en active Application Filing
- 2012-08-07 RU RU2014109015A patent/RU2622025C2/ru active
- 2012-08-07 US US13/877,891 patent/US9408912B2/en active Active
- 2012-08-07 CN CN201280038864.1A patent/CN104620334B/zh active Active
- 2012-08-07 EP EP16000350.5A patent/EP3038115B1/en active Active
- 2012-08-07 JP JP2014524301A patent/JP5844902B2/ja active Active
- 2012-08-07 DE DE202012012795U patent/DE202012012795U1/de not_active Expired - Lifetime
- 2012-08-07 BR BR112014002726A patent/BR112014002726A8/pt not_active IP Right Cessation
- 2012-08-07 EP EP12748166.1A patent/EP2742515B1/en active Active
- 2012-08-07 DK DK12748166.1T patent/DK2742515T3/en active
- 2012-08-07 AU AU2012292554A patent/AU2012292554B2/en active Active
-
2014
- 2014-01-23 ZA ZA2014/00564A patent/ZA201400564B/en unknown
- 2014-02-03 IL IL230799A patent/IL230799A/en active IP Right Grant
- 2014-02-06 CL CL2014000298A patent/CL2014000298A1/es unknown
- 2014-02-07 CO CO14026546A patent/CO6940414A2/es unknown
-
2015
- 2015-11-05 HK HK15110910.9A patent/HK1210317A1/zh unknown
-
2016
- 2016-06-30 US US15/198,708 patent/US9962442B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2012327781B2 (en) | Modified Y zeolite, method for preparing same, and use thereof | |
| AU2016216707A1 (en) | Blue-colored gold nanoparticles for immunological measurement, process for production of same, and measurement method using same | |
| SA115360532B1 (ar) | طريقة لإنتاج الترنيسيت | |
| MX2020007227A (es) | Nanoparticulas farmaceuticas que muestran la mejora del transporte de la mucosa. | |
| MX2011012196A (es) | Composiciones y metodos para el suministro de farmaco. | |
| EP2290012A3 (en) | Nanoscale pigment particle composition and process for producing same | |
| AU2012234470A8 (en) | Self-binding pigment hybrid | |
| MX341663B (es) | Nanopolvo de compuesto organico, metodo para producirlo y su suspension. | |
| MX2012000787A (es) | Un proceso para preparar una suspension acuosa de un compuesto pesticida organico. | |
| MX336683B (es) | Composiciones a base de monomeros de acido sulfonico. | |
| MX340657B (es) | Suspension acuosa de silice amorfa y metodo para su produccion. | |
| MX2013010889A (es) | Proceso para la preparacion de particulas de pigmentos autoaglutinantes. | |
| MX2014001186A (es) | Aglomeracion de nanoparticulas recubiertas con alcoxisilano magnetico. | |
| EP2290015A3 (en) | Nanoscale pigment particle composition and process for producing same | |
| PH12015502003A1 (en) | Ophthalmic formulations | |
| MX2014008999A (es) | Proceso novedoso para la preparación de sílices precipitadas que tienen una morfología específica, un tamaño de partícula específico y una porosidad específica. | |
| BR112014014762A8 (pt) | método para preparação de cisteína ou de um derivado desta usando uma nova o-fosferina sulfidrilase | |
| EP2290014A3 (en) | Nanoscale benzimidazolone pigment particle composition and process for producing same | |
| WO2014052203A3 (en) | Coatable composition, wear-resistant composition, wear-resistant articles, and methods of making the same | |
| WO2012095863A3 (en) | A process to prepare novel platinum nanoparticls and nanoparticles thereof | |
| MX2015001096A (es) | Composiciones de revestimiento. | |
| MX354220B (es) | Metodo para producir una dispersion estable de nano-particulas, la dispersion producida y el uso de la misma. | |
| GB2523674A (en) | Compounds as inhibitor of DNA double-strand break repair, methods and applications thereof | |
| WO2011131979A3 (en) | Method of forming a one dimensional nanostructure and nanostructure formed by the method | |
| MX2015009614A (es) | Método para producir formulaciones de concentrados en suspensión acuosa. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |